VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 52 filers reported holding VECTIVBIO HLDG AG in Q2 2023. The put-call ratio across all filers is 0.68 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,872,372 | -7.5% | 682,834 | -7.4% | 0.22% | -6.7% |
| Q4 2022 | $6,351,631 | +39.9% | 737,704 | -2.5% | 0.24% | +29.0% |
| Q3 2022 | $4,539,000 | +11.1% | 756,502 | 0.0% | 0.19% | +15.5% |
| Q2 2022 | $4,085,000 | +14.9% | 756,502 | 0.0% | 0.16% | +28.8% |
| Q1 2022 | $3,556,000 | -4.3% | 756,502 | 0.0% | 0.12% | +4.2% |
| Q4 2021 | $3,714,000 | -30.9% | 756,502 | 0.0% | 0.12% | -30.6% |
| Q3 2021 | $5,372,000 | +217.7% | 756,502 | +421.7% | 0.17% | +214.5% |
| Q2 2021 | $1,691,000 | – | 145,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,084,310 | $14,527,000 | 6.18% |
| Novo Holdings A/S | 3,380,402 | $15,922,000 | 0.84% |
| Cormorant Asset Management, LP | 2,078,485 | $9,790,000 | 0.75% |
| Orbimed Advisors | 5,330,704 | $25,108,000 | 0.41% |
| Bpifrance SA | 2,806,217 | $13,217,000 | 0.37% |
| Eventide Asset Management | 2,339,044 | $10,994,000 | 0.17% |
| Tekla Capital Management LLC | 756,502 | $3,556,000 | 0.12% |
| Canaan Partners XI LLC | 37,051 | $175,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 393,365 | $1,849,000 | 0.02% |
| Citadel Advisors | 2,722,646 | $12,797,000 | 0.00% |